Literature DB >> 8255961

Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture.

C H A'Court1, C S Garrard, D Crook, I Bowler, C Conlon, T Peto, E Anderson.   

Abstract

We surveyed bronchial microflora by alternate-day, non-directed bronchial lavage (NBL) in 150 patients requiring mechanical ventilation on an intensive care unit. This simple technique uses a 20 ml non-bronchoscopic lung lavage, then quantitative bacterial culture. NBL bacteriological findings were identical to those obtained by same-day bronchoscopic broncho-alveolar lavage on 16/20 occasions. Using serial NBLs, the bronchial bacterial population was characterized during 65 episodes of pneumonia defined by clinical and retrospective criteria. Mean bacterial colony counts increased significantly during the 2 days preceding the clinical onset of pneumonia, from < or = 10(3) cfu/ml to > or = 10(5) cfu/ml (p < 0.05). In 51 patients showing a clinical response to antibiotic treatment, mean colony counts fell significantly after antibiotic initiation (p < 0.05). By contrast, in 14 patients who showed progressive clinical deterioration or relapse, there was no significant fall in NBL counts, and serial NBLs revealed antibiotic resistance or superinfection. The surveillance data altered clinical management in 42% of patients. Positive NBLs guided the choice of antibiotics, whilst negative NBLs encouraged the withholding of antibiotics, or detection of alternative pathology. We propose routine bacteriological lung surveillance of mechanically ventilated patients using this simple, inexpensive and safe technique.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8255961     DOI: 10.1093/qjmed/86.10.635

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  24 in total

1.  Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability.

Authors:  Carolina A M Schurink; Christianne A Van Nieuwenhoven; Jan A Jacobs; Maja Rozenberg-Arska; Hans C A Joore; Erik Buskens; Andy I M Hoepelman; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2003-10-18       Impact factor: 17.440

2.  A new category--healthcare-associated pneumonia: a good idea, but problems with its execution.

Authors:  S Fujitani; V L Yu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-10       Impact factor: 3.267

Review 3.  Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis.

Authors:  Nele Brusselaers; Sonia Labeau; Dirk Vogelaers; Stijn Blot
Journal:  Intensive Care Med       Date:  2012-11-28       Impact factor: 17.440

Review 4.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 5.  Ventilator-associated pneumonia.

Authors:  Mv Pravin Charles; Arunava Kali; Joshy M Easow; Noyal Maria Joseph; M Ravishankar; Srirangaraj Srinivasan; Shailesh Kumar; Sivaraman Umadevi
Journal:  Australas Med J       Date:  2014-08-31

6.  Physiotherapy does not prevent, or hasten recovery from, ventilator-associated pneumonia in patients with acquired brain injury.

Authors:  Shane Patman; Sue Jenkins; Kathy Stiller
Journal:  Intensive Care Med       Date:  2008-09-24       Impact factor: 17.440

7.  High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis.

Authors:  K Thorburn; S Harigopal; V Reddy; N Taylor; H K F van Saene
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

8.  Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia.

Authors:  M J Schultz; J Millo; M Levi; C E Hack; G J Weverling; C S Garrard; T van der Poll
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

9.  Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia.

Authors:  Julian L Millo; Marcus J Schultz; Conrad Williams; Gerrit J Weverling; Timothy Ringrose; Carolyn I Mackinlay; Tom van der Poll; Christopher S Garrard
Journal:  Intensive Care Med       Date:  2003-11-21       Impact factor: 17.440

10.  Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study.

Authors:  Rogier M Determann; Julian L Millo; Sam Waddy; Rene Lutter; Chris S Garrard; Marcus J Schultz
Journal:  BMC Pulm Med       Date:  2009-12-03       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.